Business Context and Reporting Period
InMode Ltd., an Israeli medical technology company, filed this Form 6-K for August 2019. The filing reports the closing of the Company’s previously announced initial public offering and related corporate actions on August 12, 2019.
Key Financial and Capital Markets Information
- The Company issued 5,000,000 ordinary shares in the IPO.
- Aggregate gross IPO proceeds were approximately $70.0 million, before underwriting discounts, commissions, and other offering expenses.
- The filing does not provide net IPO proceeds, post-offering cash balances, operating revenue, profit, cash flow, margins, debt, or liquidity metrics.
Material Changes and Corporate Actions
- InMode entered into an underwriting agreement dated August 7, 2019, with Barclays Capital Inc. and UBS Securities LLC as representatives of the underwriters.
- The Company’s Amended and Restated Articles of Association were filed on July 29, 2019 and became effective August 7, 2019.
- The IPO closing press release was issued on August 12, 2019.
Guidance, Outlook, Risks, and Unusual Items
The filing does not provide management guidance, operating outlook, risk updates, contingencies, or discussion of unusual operating items. The principal disclosed event is the IPO and the resulting capital raise. Net proceeds and the intended use of funds are not stated in the provided filing text.
Investor Verification Checklist
- Verify the final number of shares outstanding after the IPO and any effects of underwriting discounts, commissions, and offering expenses.
- Confirm net IPO proceeds and the Company’s stated use of those proceeds.
- Review the underwriting agreement for offering terms, indemnification provisions, and other obligations.
- Review the amended and restated articles for changes to shareholder rights and corporate governance.
- Consult subsequent filings for post-IPO financial performance, cash balances, liquidity, and operating guidance.